Table of Contents
International Journal of Proteomics
Volume 2015, Article ID 536537, 12 pages
http://dx.doi.org/10.1155/2015/536537
Research Article

A Proteomic Characterization of Bordetella pertussis Clinical Isolates Associated with a California State Pertussis Outbreak

1Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Chamblee, GA 30341, USA
2Division of Bacterial Diseases, National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
3Oak Ridge Institute for Science and Education, Oak Ridge, TN 37831-0117, USA

Received 6 March 2015; Accepted 1 May 2015

Academic Editor: Michael Hippler

Copyright © 2015 Yulanda M. Williamson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Bordet and O. Gengou, “Le microbe de la coqueluche,” Annales de l'Institut Pasteur, vol. 20, pp. 48–68, 1906. View at Google Scholar
  2. M. Singh and K. Lingappan, “Whooping cough: the current scene,” Chest, vol. 130, no. 5, pp. 1547–1553, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. T. A. Clark, N. E. Messonnier, and S. C. Hadler, “Pertussis control: time for something new?” Trends in Microbiology, vol. 20, no. 5, pp. 211–213, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. Centers for Disease Control and Prevention, Surveillance & Reporting, 2014, http://www.cdc.gov/pertussis/surv-reporting.html.
  5. K. Winter, K. Harriman, R. Schechter, E. Yamada, J. Talarico, and G. Chavez, “Notes from the field: pertussis—California January through June 2010,” Morbidity and Mortality Weekly Report, vol. 59, no. 26, p. 817, 2010. View at Google Scholar
  6. K. Winter, K. Harriman, J. Zipprich et al., “California pertussis epidemic, 2010,” The Journal of Pediatrics, vol. 161, no. 6, pp. 1091–1096, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. J. D. Cherry, “Epidemic pertussis in 2012—the resurgence of a vaccine-preventable disease,” The New England Journal of Medicine, vol. 367, no. 9, pp. 785–787, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. F. R. Mooi, N. A. van der Maas, and H. E. de Melker, “Pertussis resurgence: waning immunity and pathogen adaptation—two sides of the same coin,” Epidemiology and Infection, vol. 142, no. 4, pp. 685–694, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. Q. He and J. Mertsola, “Factors contributing to pertussis resurgence,” Future Microbiology, vol. 3, no. 3, pp. 329–339, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Locht, “A common vaccination strategy to solve unsolved problems of tuberculosis and pertussis?” Microbes and Infection, vol. 10, no. 9, pp. 1051–1056, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Taylor and R. Fahim, “Pasteur Merieux Connaught five-component acellular pertussis vaccine,” Biologicals, vol. 27, no. 2, pp. 103–104, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. R. K. Gupta, S. N. Saxena, S. B. Sharma, and S. Ahuja, “Studies on the optimal conditions for inactivation of Bordetella pertussis organisms with glutaraldehyde for preparation of a safe and potent pertussis vaccine,” Vaccine, vol. 6, no. 6, pp. 491–496, 1988. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Kallonen, J. Mertsola, F. R. Mooi, and Q. He, “Rapid detection of the recently emerged Bordetella pertussis strains with the ptxP3 pertussis toxin promoter allele by real-time PCR,” Clinical Microbiology and Infection, vol. 18, no. 10, pp. E377–E379, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. A. J. Schmidtke, K. O. Boney, S. W. Martin, T. H. Skoff, M. L. Lucia Tondella, and K. M. Tatti, “Population diversity among Bordetella pertussis isolates, United States, 1935–2009,” Emerging Infectious Diseases, vol. 18, no. 8, pp. 1248–1255, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. M. J. Bart, M. van Gent, H. G. J. van der Heide et al., “Comparative genomics of prevaccination and modern Bordetella pertussis strains,” BMC Genomics, vol. 11, no. 1, article 627, pp. 1–10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. L. C. Pawloski, A. M. Queenan, P. K. Cassiday et al., “Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States,” Clinical and Vaccine Immunology, vol. 21, no. 2, pp. 119–125, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. M. Williamson, H. Moura, K. Simmons et al., “A gel-free proteomic-based method for the characterization of Bordetella pertussis clinical isolates,” Journal of Microbiological Methods, vol. 90, no. 2, pp. 119–133, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. R. West, J. Whitmon, Y. M. Williamson et al., “A rapid method for capture and identification of immunogenic proteins in Bordetella pertussis enriched membranes fractions: a fast-track strategy applicable to other microorganisms,” Journal of Proteomics, vol. 75, no. 6, pp. 1966–1972, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. B. E. Tefon, S. Maaß, E. Özcengiz, D. Becher, M. Hecker, and G. Özcengiz, “A comprehensive analysis of Bordetella pertussis surface proteome and identification of new immunogenic proteins,” Vaccine, vol. 29, no. 19, pp. 3583–3595, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Altindiş, B. E. Tefon, V. Yildirim et al., “Immunoproteomic analysis of Bordetella pertussis and identification of new immunogenic proteins,” Vaccine, vol. 27, no. 4, pp. 542–548, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Bottero, M. E. Gaillard, M. Fingermann et al., “Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains,” Clinical and Vaccine Immunology, vol. 14, no. 11, pp. 1490–1498, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Advani, D. Donnelly, and H. Hallander, “Reference system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profiles,” Journal of Clinical Microbiology, vol. 42, no. 7, pp. 2890–2897, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. I. H. M. Van Loo, K. J. Heuvelman, A. J. King, and F. R. Mooi, “Multilocus sequence typing of Bordetella pertussis based on surface protein genes,” Journal of Clinical Microbiology, vol. 40, no. 6, pp. 1994–2001, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. D. J. Litt, S. E. Neal, and N. K. Fry, “Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type,” Journal of Clinical Microbiology, vol. 47, no. 3, pp. 680–688, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. R. R. Hulbert and P. A. Cotter, “Laboratory maintenance of Bordetella pertussis,” Current Protocols in Microbiology, vol. 15, no. 4B, pp. 1.1–1.9, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. Bruker Daltonics, MALDI BioTyper 3.0 User Manual, Revision 1: Preparing Samples, B2.2:157, Bruker Daltonics, Billerica, Mass, USA, 2011.
  27. K. Lyons, “TCA/Acetone Precipitation (Large Scale),” 2003, http://www.signaling-gateway.org/data/cgi-bin/ProtocolFile.cgi/afcs_PP00000148.pdf?pid=PP00000148.
  28. A. Keller, A. I. Nesvizhskii, E. Kolker, and R. Aebersold, “Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search,” Analytical Chemistry, vol. 74, no. 20, pp. 5383–5392, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. A. I. Nesvizhskii, A. Keller, E. Kolker, and R. Aebersold, “A statistical model for identifying proteins by tandem mass spectrometry,” Analytical Chemistry, vol. 75, no. 17, pp. 4646–4658, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Y. Yu, J. R. Wagner, M. R. Laird et al., “PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes,” Bioinformatics, vol. 26, no. 13, Article ID btq249, pp. 1608–1615, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Liu, R. G. Sadygov, and J. R. Yates III, “A model for random sampling and estimation of relative protein abundance in shotgun proteomics,” Analytical Chemistry, vol. 76, no. 14, pp. 4193–4201, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. D. H. Lundgren, S.-I. Hwang, L. Wu, and D. K. Han, “Role of spectral counting in quantitative proteomics,” Expert Review of Proteomics, vol. 7, no. 1, pp. 39–53, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. A. J. King, S. van der Lee, A. Mohangoo, M. van Gent, A. van der Ark, and B. van de Waterbeemd, “Genome-wide gene expression analysis of Bordetella pertussis isolates associated with resurgence in pertussis: elucidation of factors involved in increased fitness of epidemic strains,” PLoS ONE, vol. 8, no. 6, pp. 1–10, 2013. View at Google Scholar
  34. S. Mattoo and J. D. Cherry, “Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies,” Clinical Microbiology Reviews, vol. 18, no. 2, pp. 326–382, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Shrivastava and J. F. Miller, “Virulence factor secretion and translocation by Bordetella species,” Current Opinion in Microbiology, vol. 12, no. 1, pp. 88–93, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Coutte, S. Alonso, N. Reveneau et al., “Role of adhesin release for mucosal colonization by a bacterial pathogen,” The Journal of Experimental Medicine, vol. 197, no. 6, pp. 735–742, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. F. R. Mooi, I. H. M. van Loo, M. Van Gent et al., “Bordetella pertussis strains with increased toxin production associated with pertussis resurgence,” Emerging Infectious Diseases, vol. 15, no. 8, pp. 1206–1213, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Emsley, G. McDermott, I. G. Charles, N. F. Fairweather, and N. W. Isaacs, “Crystallographic characterization of pertactin, a membrane-associated protein from Bordetella pertussis,” Journal of Molecular Biology, vol. 235, no. 2, pp. 772–773, 1994. View at Publisher · View at Google Scholar · View at Scopus
  39. S. M. M. Hellwig, M. E. Rodriguez, G. A. M. Berbers, J. G. J. van de Winkel, and F. R. Mooi, “Crucial role of antibodies to pertactin in Bordetella pertussis immunity,” The Journal of Infectious Diseases, vol. 188, no. 5, pp. 738–742, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. T. L. Williams, J. L. Pirkle, and J. R. Barr, “Simultaneous quantification of hemagglutinin and neuraminidase of influenza virus using isotope dilution mass spectrometry,” Vaccine, vol. 30, no. 14, pp. 2475–2482, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Winter, C. Glaser, J. Watt et al., “Pertussis epidemic—California, 2014,” Morbidity and Mortality Weekly Report, vol. 63, pp. 1129–1132, 2014. View at Google Scholar
  42. J. M. Warfel, J. Beren, V. K. Kelly, G. Lee, and T. J. Merkel, “Nonhuman primate model of pertussis,” Infection and Immunity, vol. 80, no. 4, pp. 1530–1536, 2012. View at Publisher · View at Google Scholar · View at Scopus